Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.

Abstract:

:Lymphatic filariasis (LF) is an important public health problem endemic in 73 countries, where it is a major cause of acute and chronic morbidity and a significant impediment to socioeconomic development. It is targeted for elimination by 2020, through preventive chemotherapy using albendazole in combination with either ivermectin or diethylcarbamazine citrate. Preventive chemotherapy enables the regular and coordinated administration of safe, single-dose medications delivered through mass drug administration (MDA). Many countries are now scaling down MDA activities after achieving 100% geographic coverage and instituting monitoring and evaluation procedures to establish the impact of several consecutive rounds of MDA and determine if transmission has been interrupted. At the same time, countries yet to initiate MDA for elimination of LF will adopt improved mapping and coverage assessment protocols to accelerate the efforts for achieving global elimination by 2020. This review provides an update on treatment for LF and describes the current global status of the elimination efforts, transmission control processes and strategies for measuring impact and continuing surveillance after MDA has ceased.

authors

Rebollo MP,Bockarie MJ

doi

10.1586/14787210.2013.811841

subject

Has Abstract

pub_date

2013-07-01 00:00:00

pages

723-31

issue

7

eissn

1478-7210

issn

1744-8336

journal_volume

11

pub_type

杂志文章,评审
  • Efavirenz-based antiretroviral therapy versus nevirapine-including regimens for prevention of mother-to-child transmission of HIV option B plus in resource-limited settings: is there anything missing?

    abstract::In 2013, an estimated 1.5 million HIV-positive pregnant women gave birth, with 240,000 children worldwide acquiring HIV. More than 90% of new pediatric infections occurred in Sub-Saharan Africa. The latest WHO guidelines recommended efavirenz (EFV)-based antiretroviral therapy as the first-line regimen for prevention ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2016.1116383

    authors: De Nardo P,Gentilotti E,Nguhuni B,Vairo F,Chaula Z,Nicastri E,Ippolito G

    更新日期:2016-01-01 00:00:00

  • Sertaconazole: updated review of a topical antifungal agent.

    abstract::Sertaconazole is an imidazole-type antifungal agent that has shown considerable in vitro activity against pathogenic fungi. Various studies carried out in animal models, clinical and toxicologic trials have confirmed the value of sertaconazole in the topical treatment of superficial mycoses in dermatology and gynecolo...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.3.3.333

    authors: Carrillo-Muñoz AJ,Giusiano G,Ezkurra PA,Quindós G

    更新日期:2005-06-01 00:00:00

  • Prevention of influenza in healthy children.

    abstract::Healthy children are high transmitters of influenza and can experience poor influenza outcomes. Many questions remain about the efficacy and impect of preventive measures because most existing studies report imprecise proxies of influenza incidence, do not follow subjects throughout the entire influenza season and acr...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.12.106

    authors: Lee BY,Shah M

    更新日期:2012-10-01 00:00:00

  • A cross-sectional study evaluating the knowledge and beliefs about, and the use of antibiotics amongst Malaysian university students.

    abstract:BACKGROUND:The introduction of antibiotics into modern medicine has changed clinical care by saving millions of lives. However, misuse of antibiotics has led to their benefits being overshadowed by the development of antimicrobial resistance. AIMS OF STUDY:This study aimed to assess university students' knowledge and ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1080/14787210.2019.1581607

    authors: Haque M,Rahman NAA,McKimm J,Binti Abdullah SL,Islam MZ,Zulkifli Z,Saidin NB,Azhar NIK,Binti Lutfi SNN,Binti Othman NSA

    更新日期:2019-04-01 00:00:00

  • Trends in antifungal susceptibility testing using CLSI reference and commercial methods.

    abstract::Antifungal susceptibility testing should identify in vitro resistance among a normally susceptible population or should detect the development of resistance during therapy. The Clinical and Laboratory Standards Institute (CLSI; formerly the National Committee for Clinical Laboratory Standards [NCCLS]) has developed re...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.7.1.107

    authors: Cantón E,Espinel-Ingroff A,Pemán J

    更新日期:2009-02-01 00:00:00

  • Syphilis incidence in men who have sex with men with human immunodeficiency virus comorbidity and the importance of integrating sexually transmitted infection prevention into HIV care.

    abstract:INTRODUCTION:Syphilis continues to be a growing epidemic among men who have sex with men (MSM), particularly for those living with the human immunodeficiency virus (HIV). In 2016, MSM accounted for 80% of primary and secondary syphilis diagnoses in men in the United States; almost half of who were also HIV-infected. Th...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2018.1446828

    authors: Refugio ON,Klausner JD

    更新日期:2018-04-01 00:00:00

  • Influenza infection in human host: challenges in making a better influenza vaccine.

    abstract::Influenza is a ubiquitous infection with a spectrum ranging from mild to severe. The mystery regarding such variability in the clinical spectrum has not been fully unravelled, although a role for the complex interplay among virus characteristics, host immune response and environmental factors has been suggested. Antiv...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2016.1155450

    authors: Virk RK,Gunalan V,Tambyah PA

    更新日期:2016-01-01 00:00:00

  • MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.

    abstract:INTRODUCTION:COVID-19 disease progresses through a number of distinct phases. The management of each phase is unique and specific. The pulmonary phase of COVID-19 is characterized by an organizing pneumonia with profound immune dysregulation, activation of clotting, and a severe microvascular injury culminating in seve...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1080/14787210.2020.1808462

    authors: Marik PE,Kory P,Varon J,Iglesias J,Meduri GU

    更新日期:2020-08-18 00:00:00

  • Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review.

    abstract::Lymphogranuloma venereum (LGV) is a sexually transmitted infection, previously only seen in tropical regions. This changed in 2003 when the first endemically acquired LGV cases were reported in Rotterdam, the Netherlands, among predominantly HIV positive men who have sex with men (MSM). Early diagnosis is important to...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2014.901169

    authors: de Vrieze NH,de Vries HJ

    更新日期:2014-06-01 00:00:00

  • Darunavir/cobicistat once daily for the treatment of HIV.

    abstract::A current focus in HIV management is improving adherence by minimizing pill burden with convenient formulations, including fixed-dose combinations (FDCs). Darunavir, a HIV protease inhibitor, co-administered with low-dose ritonavir (800/100 mg once daily), is recommended in guidelines in combination with other antiret...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2015.1033400

    authors: Kakuda TN,Crauwels H,Opsomer M,Tomaka F,van de Casteele T,Vanveggel S,Iterbeke K,de Smedt G

    更新日期:2015-06-01 00:00:00

  • Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

    abstract:INTRODUCTION:The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is an important emerging respiratory pathogen. MERS-CoV resulted in multiple hospital outbreaks within and outside the Arabian Peninsula. The disease has a high case fatality rate, with the need for a therapeutic option. Areas covered: In this rev...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2017.1271712

    authors: Al-Tawfiq JA,Memish ZA

    更新日期:2017-03-01 00:00:00

  • The glory of guidelines and the twilight of reality: controversies and challenges in the prevention and treatment of HIV in children.

    abstract::Since the discovery of HIV 30 years ago, we have learned much about HIV in children and adolescents. Dramatic declines have occurred in mother-to-child transmission of HIV in resource-rich countries. Resource-poor countries struggle with improving prevention of mother-to-child transmission due to the lack of universal...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.12.60

    authors: Anderson EJ,Yogev R

    更新日期:2012-07-01 00:00:00

  • Invasive pulmonary aspergillosis.

    abstract::In susceptible patients, invasive aspergillosis has a high incidence and a mortality of up to 80%. The diagnosis of this condition is difficult, especially in the early stages of the disease and, as a consequence, antifungal therapy, despite its expense and toxicity, is often initiated empirically. Until recently, the...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.3.4.613

    authors: Doffman SR,Agrawal SG,Brown JS

    更新日期:2005-08-01 00:00:00

  • Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients.

    abstract::Despite significant advances in the day-to-day management of patients receiving hematopoietic stem cell transplantations, including the introduction of new antiviral drugs, cytomegalovirus (CMV) infection continues to be a major cause of morbidity and mortality. The aim of this article is to undertake a literature-bas...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.12.115

    authors: Bacigalupo A,Boyd A,Slipper J,Curtis J,Clissold S

    更新日期:2012-11-01 00:00:00

  • Natural killer cells in immunodefense against infective agents.

    abstract::Following the discovery of innate immune receptors, the topics of innate immunity and its role in defense against infective agents have recently blossomed into very active research fields, after several decades of neglect. Among innate immune cells, natural killer (NK) cells are endowed with the unique ability to reco...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.6.6.867

    authors: Zucchini N,Crozat K,Baranek T,Robbins SH,Altfeld M,Dalod M

    更新日期:2008-12-01 00:00:00

  • Clinical management of women with listeriosis risk during pregnancy: a review of national guidelines.

    abstract:INTRODUCTION:Listeriosis is an uncommon foodborne infection that may cause moderate maternal illness, but can be extremely serious for the fetus and the newborn. Several guidelines have been elaborated in order to help clinicians on the care of pregnant women with known or suspected exposure to Listeria monocytogenes. ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2018.1417837

    authors: Pucci L,Massacesi M,Liuzzi G

    更新日期:2018-01-01 00:00:00

  • Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection.

    abstract::The fixed dose combination of abacavir with lamivudine represents a new treatment option for patients infected with HIV. Fixed dose combination abacavir/lamivudine has the convenience of one pill and once-daily dosing. It achieves comparable suppression of plasma HIV RNA with the pill's individual components dosed twi...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.3.6.871

    authors: Anderson AM,Bartlett JA

    更新日期:2005-12-01 00:00:00

  • Antibody response to Salmonella: its induction and role in protection against avian enteric salmonellosis.

    abstract::Human enteritis resulting from the consumption of poultry products contaminated with serovars of Salmonella enterica remains a major public-health concern. Reducing food contamination by preventing or controlling infection in the chicken during rearing is an attractive solution. An accurate understanding of the mechan...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.5.5.873

    authors: Beal RK,Smith AL

    更新日期:2007-10-01 00:00:00

  • Delivery of host cell-directed therapeutics for intracellular pathogen clearance.

    abstract::Intracellular pathogens present a major health risk because of their innate ability to evade clearance. Their location within host cells and ability to react to the host environment by mutation or transcriptional changes often enables survival mechanisms to resist standard therapies. Host-directed drugs do not target ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2013.845524

    authors: Collier MA,Gallovic MD,Peine KJ,Duong AD,Bachelder EM,Gunn JS,Schlesinger LS,Ainslie KM

    更新日期:2013-11-01 00:00:00

  • Evidence-based guidelines for the management of Lyme disease.

    abstract::This report, completed in November 2003, is intended to serve as a resource for physicians, public health officials and organizations involved in the evaluation and treatment of Lyme disease. ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 指南,杂志文章,实务指引

    doi:10.1586/14789072.2.1.s1

    authors: Cameron D,Gaito A,Harris N,Bach G,Bellovin S,Bock K,Bock S,Burrascano J,Dickey C,Horowitz R,Phillips S,Meer-Scherrer L,Raxlen B,Sherr V,Smith H,Smith P,Stricker R,ILADS Working Group.

    更新日期:2004-01-01 00:00:00

  • Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility.

    abstract:INTRODUCTION:The emergence of carbapenem-resistant Enterobacteriaceae (CRE) has brought aminoglycosides to the frontline since an aminoglycoside may be the only antimicrobial to which CRE isolates show in vitro susceptibility. The appropriateness of aminoglycoside-based therapies for severe infections by CRE is discuss...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2017.1316193

    authors: Zavascki AP,Klee BO,Bulitta JB

    更新日期:2017-06-01 00:00:00

  • The use of fluoroquinolones in children: recent advances.

    abstract::Fluoroquinolones are an important group of antibiotics that are used widely in the treatment of various infectious diseases in adults as a result of their excellent spectrum of activity, significant tissue penetration and convenient routes of administration. Their use in children, however, has been limited until recen...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.4.5.853

    authors: Velissariou IM

    更新日期:2006-10-01 00:00:00

  • Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.

    abstract::Ceftobiprole is among the first of a new generation of cephalosporins with activity against aerobic Gram-negative bacilli, which extends to cefepime-sensitive Pseudomonas aeruginosa, and activity against Gram-positive organisms, which includes methicillin-resistant Staphylococcus aureus. Ceftobiprole is currently unde...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.09.54

    authors: Schirmer PL,Deresinski SC

    更新日期:2009-09-01 00:00:00

  • Entecavir for the treatment of chronic hepatitis B.

    abstract::Chronic infection with the hepatitis B virus remains a serious and life-threatening disease for approximately 5% of the world's population, despite the availability of effective vaccines. Although prognoses can be improved by chemotherapy, treatment options are limited and none has been consistently successful. Interf...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14789072.2.6.853

    authors: Shaw T,Locarnini S

    更新日期:2004-12-01 00:00:00

  • Prevention and treatment of viral diarrhea in pediatrics.

    abstract::Diarrhea is the second largest cause of mortality worldwide in children from the perinatal period to the age of 5 years. Rotavirus has been the most commonly identified viral cause of diarrhea in children. Norovirus is now recognized as the second most common viral pathogen. Adenovirus, astrovirus and sapovirus are th...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.10.1

    authors: Anderson EJ

    更新日期:2010-02-01 00:00:00

  • Recent progress in the repurposing of drugs/molecules for the management of COVID-19.

    abstract::Introduction: In the current scenario, COVID-19 is a clinical and public health problem globally. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) remains the causative agent, emerged in China and continuously spreading across the globe. Until now, no efficient therapeutics have been approved, which combat...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1080/14787210.2021.1860020

    authors: Sharma D,Kunamneni A

    更新日期:2020-12-10 00:00:00

  • Role of GB virus C in modulating HIV disease.

    abstract::GB virus C (GBV-C) is a member of the Flaviviridae family and the most closely related human virus to HCV. However, GBV-C does not replicate in hepatocytes, but rather in lymphocytes. GBV-C has a worldwide distribution and is transmitted sexually, parenterally and through mother-to-child transmission. Thus, co-infecti...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.12.37

    authors: Schwarze-Zander C,Blackard JT,Rockstroh JK

    更新日期:2012-05-01 00:00:00

  • Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.

    abstract::Bacillus anthracis is the causative agent of anthrax, a disease that plagues both humans and various animal species. Effective vaccines are available, but those approved for human use are crude culture supernatants that require multiple injections and a yearly boost. Many experts agree that it is now time for the next...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.7.2.219

    authors: Tournier JN,Ulrich RG,Quesnel-Hellmann A,Mohamadzadeh M,Stiles BG

    更新日期:2009-03-01 00:00:00

  • Extended or continuous versus short-term intravenous infusion of cephalosporins: a meta-analysis.

    abstract::The authors sought to study whether extended or continuous infusion of cephalosporins is associated with better clinical outcomes than short-term infusion. PubMed and Scopus databases were systematically searched. Studies reporting the clinical outcomes of patients receiving extended or continuous infusion (≥3 or 24 h...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,meta分析

    doi:10.1586/eri.13.44

    authors: Korbila IP,Tansarli GS,Karageorgopoulos DE,Vardakas KZ,Falagas ME

    更新日期:2013-06-01 00:00:00

  • Management of candidemia in patients with Clostridium difficile infection.

    abstract:INTRODUCTION:Patients with C. difficile infection (CDI) experience intestinal microflora changes that can promote the overgrowth and subsequent translocation of gut resident pathogens into the blood. Consistently, CDI due to PCR-ribotype 027 strain, severe or relapsing CDI, and treatment with high-dosage vancomycin are...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2016.1197118

    authors: Falcone M,Venditti M,Sanguinetti M,Posteraro B

    更新日期:2016-07-01 00:00:00